Targeting inflammation-induced transcription factor activation: An open frontier for glioma therapy

Drug Discovery Today

Volumn 16, Issue 23-24, 2011, Pages 1044-1051

  Sen, Ellora ^a  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN INHIBITOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CARCINOGENESIS; CELL SURVIVAL; DRUG MECHANISM; DRUG RESEARCH; DRUG TARGETING; GLIOBLASTOMA; HUMAN; INFLAMMATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; INFLAMMATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 82255162738     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.09.003     Document Type: Review

References (148)

1. S.I. Grivennikov Immunity, inflammation, and cancer Cell 140 2010 883 899
2. B. Ancrile Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis Genes Dev. 21 2007 1714 1719 (Pubitemid 47076470)
3. A. Mantovani Cancer-related inflammation Nature 454 2008 436 444
4. A. Sparmann, and D. Bar-Sagi Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis Cancer Cell 6 2004 447 458 (Pubitemid 39469981)
5. F. Rodier Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion Nat. Cell Biol. 11 2009 973 979
6. W.X. Zong, and C.B. Thompson Necrotic death as a cell fate Genes Dev. 20 2006 1 15 (Pubitemid 43042662)
7. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867 (Pubitemid 36019639)
8. A. Albini, and M.B. Sporn The tumour microenvironment as a target for chemoprevention Nat. Rev. Cancer 7 2007 139 147 (Pubitemid 46160989)
9. F. Balkwill Tumour necrosis factor and cancer Nat. Rev. Cancer 9 2009 361 371
10. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545 (Pubitemid 32173595)
11. B.B. Aggarwal Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe Clin. Cancer Res. 15 2009 425 430
12. R. Medzhitov, and T. Horng Transcriptional control of the inflammatory response Nat. Rev. Immunol. 9 2009 692 703
13. Smale, S.T. (2010) Selective transcription in response to an inflammatory stimulus. Cell 140, 833-844
14. J.E. Darnell Jr. Transcription factors as targets for cancer therapy Nat. Rev. Cancer 2 2002 740 749 (Pubitemid 37328909)
15. S.I. Grivennikov, and M. Karin Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer Cytokine Growth Factor Rev. 21 2010 11 19
16. H. Yu, and R. Jove The STATs of cancer - new molecular targets come of age Nat. Rev. Cancer 4 2004 97 105 (Pubitemid 38198738)
17. H. Yu Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Nat. Rev. Immunol. 7 2007 41 51 (Pubitemid 46020826)
18. H. Yu STATs in cancer inflammation and immunity: a leading role for STAT3 Nat. Rev. Cancer 9 2009 798 809
19. G.P. Atkinson NF-kappaB and STAT3 signaling in glioma: targets for future therapies Expert Rev. Neurother. 10 2010 575 586
20. J. Bollrath, and F.R. Greten IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis EMBO Rep. 10 2009 1314 1319
21. N.C. Reich, and L. Liu Tracking STAT nuclear traffic Nat. Rev. Immunol. 6 2006 602 612 (Pubitemid 44134093)
22. E.C. Brantley, and E.N. Benveniste Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas Mol. Cancer Res. 6 2008 675 684
23. H. Lee Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors Cancer Cell 15 2009 283 293
24. H. Lu Inflammation, a key event in cancer development Mol. Cancer Res. 4 2006 221 233
25. G.L. Semenza Hypoxia-inducible factor 1: master regulator of O2 homeostasis Curr. Opin. Genet. Dev. 8 1998 588 594 (Pubitemid 28477364)
26. M.C. Brahimi-Horn, and J. Pouyssegur HIF at a glance J. Cell Sci. 122 2009 1055 1057
27. T. Hellwig-Burgel Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1 Blood 94 1999 1561 1567 (Pubitemid 29411306)
28. Y.J. Jung IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis FASEB J. 17 2003 2115 2117
29. Y. Jung Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation Biochem. J. 370 2003 1011 1017 (Pubitemid 36399095)
30. J.E. Jung STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells FASEB J. 19 2005 1296 1298 (Pubitemid 41113728)
31. G.L. Semenza HIF-1 and tumor progression: pathophysiology and therapeutics Trends Mol. Med. 8 Suppl. 4 2002 62 67
32. S. Deorah Trends in brain cancer incidence and survival in the United States: Surveillance Epidemiology, and End Results Program, 1973 to 2001 Neurosurg. Focus 20 2006 1
33. D.M. Park Medical oncology: treatment and management of malignant gliomas Nat. Rev. Clin. Oncol. 7 2010 75 77
34. C.Y. Chang Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme J. Clin. Neurosci. 12 2005 930 933
35. C. Hao Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1 Th2 and Th3 cytokine dysregulation Acta Neuropathol. 103 2002 171 178 (Pubitemid 36067496)
36. R.N. Apte The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions Cancer Metastasis Rev. 25 2006 387 408 (Pubitemid 44922357)
37. E. Voronov IL-1 is required for tumor invasiveness and angiogenesis Proc. Natl. Acad. Sci. U.S.A. 100 2003 2645 2650 (Pubitemid 36297552)
38. V. Sharma Ras regulates interleukin-1beta-induced HIF-1alpha transcriptional activity in glioblastoma J. Mol. Med. (Berl.) 89 2010 123 136
39. T. Lu Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways Proc. Natl. Acad. Sci. U.S.A. 104 2007 4365 4370 (Pubitemid 47186232)
40. L.A.J. O'Neill The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense Sci. STKE 2000 2000 1
41. S. Chakraborty Inflammasome signaling at the heart of central nervous system pathology J. Neurosci. Res. 88 2010 1615 1631
42. G.Q. Wu PYRIN domain of NALP2 inhibits cell proliferation and tumor growth of human glioblastoma Plasmid 64 2010 41 50
43. C.S. Williams The role of cyclooxygenases in inflammation, cancer, and development Oncogene 18 1999 7908 7916 (Pubitemid 30066236)
44. T. Shono Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations Cancer Res. 61 2001 4375 4381 (Pubitemid 32685762)
45. A. Sasaki Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts, and glioblastoma cell lines Brain Tumor Pathol. 18 2001 13 21
46. E. Van Meir Human glioblastoma cells release interleukin 6 in vivo and in vitro Cancer Res. 50 1990 6683 6688 (Pubitemid 20348800)
47. C. Piperi High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome Mol. Med. 16 2010 1 9
48. S.O. Rahaman Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2 Cancer Res. 65 2005 2956 2963 (Pubitemid 40490101)
49. S.M. Cheng Interferon-gamma regulation of TNFalpha-induced matrix metalloproteinase 3 expression and migration of human glioma T98G cells Int. J. Cancer 121 2007 1190 1196 (Pubitemid 47293784)
50. V. Sharma Ebselen sensitizes glioblastoma cells to tumor necrosis factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex Int. J. Cancer 123 2008 2204 2212
51. B. Sredni Ammonium trichloro(dioxoethylene-o,o′)tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop Cancer Res. 64 2004 1843 1852 (Pubitemid 38428710)
52. W.W. Lin, and M. Karin A cytokine-mediated link between innate immunity, inflammation, and cancer J. Clin. Invest. 117 2007 1175 1183 (Pubitemid 46718402)
53. A. Kehlen Interleukin-17 stimulates the expression of IkappaB alpha mRNA and the secretion of IL-6 and IL-8 in glioblastoma cell lines J. Neuroimmunol. 101 1999 1 6 (Pubitemid 29505167)
54. A. Wesolowska Microglia-derived TGF-beta as an important regulator of glioblastoma invasion - an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor Oncogene 27 2008 918 930 (Pubitemid 351225378)
55. Y. Zhou CXCR4 is a major chemokine receptor on glioma cells and mediates their survival J. Biol. Chem. 277 2002 49481 49487 (Pubitemid 36014384)
56. M. Ehtesham CXCR4 expression mediates glioma cell invasiveness Oncogene 25 2006 2801 2806
57. S.F. Soriano Functional inactivation of CXC chemokine receptor 4-mediated responses through SOCS3 up-regulation J. Exp. Med. 196 2002 311 321 (Pubitemid 34875661)
58. D.J. Brat The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis Neuro-Oncol. 7 2005 122 133 (Pubitemid 40590513)
59. J. Held-Feindt CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs) Exp. Cell Res. 316 2010 1553 1566
60. G. Sciume CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1 Neuro-Oncol. 12 2010 701 710
61. A. Mantovani Role of tumor-associated macrophages in tumor progression and invasion Cancer Metastasis Rev. 25 2006 315 322 (Pubitemid 44922352)
62. S.F. Hussain The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses Neuro-Oncol. 8 2006 261 279 (Pubitemid 46542651)
63. Y. Komohara Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas J. Pathol. 216 2008 15 24
64. A. Nishie Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas Clin. Cancer Res. 5 1999 1107 1113 (Pubitemid 29233226)
65. F.R. Greten IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 2004 285 296 (Pubitemid 39061110)
66. M.S. Hayden, and S. Ghosh Shared principles in NF-kappaB signaling Cell 132 2008 344 362
67. P.A. Robe In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas Clin. Cancer Res. 10 2004 5595 5603 (Pubitemid 39100501)
68. N. Festjens RIP1, a kinase on the crossroads of a cell's decision to live or die Cell Death Differ. 14 2007 400 410
69. S. Park RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN Cancer Res. 69 2009 4107 4111
70. M. Zheng Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2 Cancer Res. 68 2008 7570 7578
71. A. Guha Ras-GTP levels are elevated in human NF1 peripheral nerve tumors Oncogene 12 1996 507 513 (Pubitemid 26059644)
72. J.S. Russell Inhibition of radiation-induced nuclear factor-kappaB activation by an anti-Ras single-chain antibody fragment: lack of involvement in radiosensitization Cancer Res. 62 2002 2318 2326 (Pubitemid 34411711)
73. D. Zagzag Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression Cancer 88 2000 2606 2618 (Pubitemid 30331970)
74. R. Blum Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death Cancer Res. 65 2005 999 1006 (Pubitemid 40216462)
75. W. Zundel Loss of PTEN facilitates HIF-1-mediated gene expression Genes Dev. 14 2000 391 396 (Pubitemid 30131884)
76. S. Zhao Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha Science 324 2009 261 265
77. S. Kaluz, and E.G. Van Meir At the crossroads of cancer and inflammation: Ras rewires an HIF-driven IL-1 autocrine loop J. Mol. Med. 89 2011 91 94
78. S. Akira, and K. Takeda Toll-like receptor signalling Nat. Rev. Immunol. 4 2004 499 511 (Pubitemid 38931765)
79. Y. Meng Expression of TLR9 within human glioblastoma J. Neurooncol. 88 2008 19 25
80. R. Tewari Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma J. Mol. Med. (Berl) 2011 in press
81. S.O. Rahaman Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells Oncogene 21 2002 8404 8413 (Pubitemid 36054883)
82. E.C. Brantley Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression Clin. Cancer Res. 14 2008 4694 4704
83. M. Wu LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses J. Cell. Physiol. 214 2008 65 74 (Pubitemid 350220060)
84. M. Wu LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-kappaB pathway Mol. Biol. Cell 17 2006 3534 3542 (Pubitemid 44156446)
85. M. Abou-Ghazal The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas Clin. Cancer Res. 14 2008 8228 8235
86. A.C. Bharti, and B.B. Aggarwal Nuclear factor-kappa B and cancer: its role in prevention and therapy Biochem. Pharmacol. 64 2002 883 888 (Pubitemid 35238030)
87. B. Raychaudhuri Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype J. Neurooncol. 85 2007 39 47 (Pubitemid 47422655)
88. T.X. Xie Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor Int. J. Oncol. 33 2008 5 15
89. N.L. Tran The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression J. Biol. Chem. 280 2005 3483 3492 (Pubitemid 40223813)
90. C. Gabellini Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma J. Neurochem. 107 2008 871 882
91. A. Watanabe Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression J. Neurooncol. 77 2006 25 32 (Pubitemid 43870558)
92. P.O. Esteve Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B J. Biol. Chem. 277 2002 35150 35155
93. S. Park The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma Cancer Res. 69 2009 2809 2816
94. M. Penzo Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis J. Immunol. 184 2010 4497 4509 (corrected)
95. R. Bassi HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration J. Neurooncol. 87 2008 23 33
96. I. Garkavtsev The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis Nature 428 2004 328 332 (Pubitemid 38418804)
97. A.H. Coles Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity Proc. Natl. Acad. Sci. U.S.A. 107 2010 11423 11428
98. A. Ueda NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene J. Immunol. 153 1994 2052 2063
99. B. Kaur Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis Neuro-Oncol. 7 2005 134 153 (Pubitemid 40590514)
100. S. Sinha IGF-1 induced HIF-1alpha-TLR9 cross talk regulates inflammatory responses in glioma Cell. Signal 23 2011 1869 1875
101. D. Zagzag Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion Lab. Invest. 86 2006 1221 1232 (Pubitemid 44789912)
102. G.L. Semenza Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 29 2010 625 634
103. K. Shuai, and B. Liu Regulation of gene-activation pathways by PIAS proteins in the immune system Nat. Rev. Immunol. 5 2005 593 605 (Pubitemid 41113191)
104. A. Bruna High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene Cancer Cell 11 2007 147 160 (Pubitemid 46209848)
105. H. Zhou Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme Clin. Cancer Res. 13 2007 2344 2353 (Pubitemid 46698583)
106. S. Loeffler Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1 Int. J. Cancer 115 2005 202 213 (Pubitemid 40586728)
107. P. Repovic Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells Oncogene 22 2003 8117 8124 (Pubitemid 37487302)
108. H.W. Lo Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes Mol. Cancer Res. 8 2010 232 245
109. H.W. Lo Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators Clin. Cancer Res. 14 2008 6042 6054
110. R. Galli Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Res. 64 2004 7011 7021 (Pubitemid 39331011)
111. S.K. Singh Identification of human brain tumour initiating cells Nature 432 2004 396 401 (Pubitemid 39551674)
112. B. Annabi A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells J. Neuroinflamm. 6 2009 8
113. Z. Li Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells Cancer Cell 15 2009 501 513
114. Sharma, V. et al. (2011) COX-2 regulates the proliferation of glioma stem like cells. Neurochem. Int, in press
115. J. Lee Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells Cancer Cell 13 2008 69 80 (Pubitemid 350309742)
116. C. Villalva STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy? Int. J. Cancer 128 2011 826 838
117. M.M. Sherry STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells Stem Cells 27 2009 2383 2392
118. J. Wei Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway Mol. Cancer Ther. 9 2010 67 78
119. X. Fan NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts Stem Cells 28 2010 5 16
120. W. Chearwae, and J.J. Bright PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells Br. J. Cancer 99 2008 2044 2053
121. P.S. Mischel, and T.F. Cloughesy Targeted molecular therapy of GBM Brain Pathol. 13 2003 52 61 (Pubitemid 36133792)
122. K. Garber First results for agents targeting cancer-related inflammation J. Natl. Cancer Inst. 101 2009 1110 1112
123. Y. Fujiwara Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages Cancer Sci. 102 2011 206 211
124. P.A. Robe Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults BMC Cancer 9 2009 372
125. A.M. Hui Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells Cancer Res. 64 2004 9115 9123
126. C. Kasuga Sensitization of human glioblastomas to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by NF-kappaB inhibitors Cancer Sci. 95 2004 840 844 (Pubitemid 39545592)
127. K. Wakabayashi Inhibitory effects of cyclosporin A on calcium mobilization-dependent interleukin-8 expression and invasive potential of human glioblastoma U251MG cells Oncogene 23 2004 6924 6932 (Pubitemid 39279993)
128. R. Tewari Ebselen abrogates TNFalpha induced pro-inflammatory response in glioblastoma Mol. Oncol. 3 2009 77 83
129. S. Karmakar Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice Cancer 112 2008 596 607 (Pubitemid 351186200)
130. B. Fuh LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model Br. J. Cancer 100 2009 106 112
131. A. Iwamaru A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo Oncogene 26 2007 2435 2444 (Pubitemid 46597261)
132. S.F. Hussain A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients Cancer Res. 67 2007 9630 9636 (Pubitemid 47621208)
133. F. Yang Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3 Mol. Cancer Ther. 9 2010 953 962
134. D. Dixit Manumycin inhibits STAT3, telomerase activity and growth of glioma cells by elevating intracellular reactive oxygen species generation Free Radic. Biol. Med. 47 2009 364 374
135. N. Koul Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells BMC Cancer 10 2010 328
136. A. Rapisarda Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts Cancer Res. 64 2004 6845 6848 (Pubitemid 39330988)
137. A. Rapisarda Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition Mol. Cancer Ther. 8 2009 1867 1877
138. D.E. Post Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4 Cancer Res. 67 2007 6872 6881 (Pubitemid 47105534)
139. C. Tan Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway Cancer Res. 65 2005 605 612
140. J. Weissenberger IL-6 is required for glioma development in a mouse model Oncogene 23 2004 3308 3316 (Pubitemid 38669820)
141. A. Mintz Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma J. Neurooncol. 64 2003 117 123 (Pubitemid 36992466)
142. T. Joki Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398 Cancer Res. 60 2000 4926 4931
143. K.B. Kang Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis Int. J. Radiat. Oncol. Biol. Phys. 67 2007 888 896 (Pubitemid 46215892)
144. D.A. Reardon Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma Cancer 103 2005 329 338 (Pubitemid 40129293)
145. M.E. Hegi MGMT gene silencing and benefit from temozolomide in glioblastoma N. Engl. J. Med. 352 2005 997 1003 (Pubitemid 40349502)
146. N. de la Iglesia Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness J. Neurosci. 28 2008 5870 5878
147. N. de la Iglesia Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway Genes Dev. 22 2008 449 462 (Pubitemid 351272753)
148. D.W. Parsons An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812